Seizure News and Research RSS Feed - Seizure News and Research

An epileptic seizure, occasionally referred to as a fit, is defined as a transient symptom of "abnormal excessive or synchronous neuronal activity in the brain".
Study sheds light on mechanism of empty memories in epileptic patients

Study sheds light on mechanism of empty memories in epileptic patients

Between seizures and continually, brain cells in epileptic patients send signals that make "empty memories," perhaps explaining the learning problems faced by up to 40 percent of patients. This is the finding of a study in rats and humans led by researchers at NYU Langone Medical Center and published April 25 in Nature Medicine. [More]
Antidepressant Wellbutrin linked to long-term modest weight loss

Antidepressant Wellbutrin linked to long-term modest weight loss

Group Health researchers have found that bupropion (marketed as Wellbutrin) is the only antidepressant that tends to be linked to long-term modest weight loss. [More]
Penn researchers report results of CAR therapy trial in brain cancer patients

Penn researchers report results of CAR therapy trial in brain cancer patients

Immune cells engineered to seek out and attack a type of deadly brain cancer known as glioblastoma (GBM) were found to have an acceptable safety profile and successfully migrate to and infiltrate tumors, researchers from Penn Medicine and Harvard University reported at the AACR Annual Meeting 2016. [More]
Epileptologists develop mobile sensor that can detect seizures

Epileptologists develop mobile sensor that can detect seizures

For epilepsy patients and attending physicians, it has been a challenge to correctly assess the frequency and severity of epileptic seizures without inpatient recording equipment. A consortium coordinated by the epileptologists of the University Hospital Bonn is now developing a mobile sensor that can detect seizures. [More]
Patient's personal activity tracker, smartphone can help physicians treat new-onset atrial fibrillation

Patient's personal activity tracker, smartphone can help physicians treat new-onset atrial fibrillation

Emergency physicians used a patient's personal activity tracker and smartphone to identify the time his heart arrhythmia started, which allowed them to treat his new-onset atrial fibrillation with electrical cardioversion and discharge him home. [More]
Article provides specific nursing considerations related to caring for patients experiencing prolonged seizure

Article provides specific nursing considerations related to caring for patients experiencing prolonged seizure

Time is of the essence when a patient experiences a prolonged seizure, and immediate action is required to prevent long-term neurological damage, according to an article in the April issue of Critical Care Nurse. [More]
Seizure-free childhood epilepsy could lead to suboptimal social, educational outcomes in young adults

Seizure-free childhood epilepsy could lead to suboptimal social, educational outcomes in young adults

Learning difficulties and behavioral problems during childhood can lead to suboptimal social and educational outcomes among young adults with childhood epilepsy even when their seizures are well under control and their disease in remission, according to findings from a study led by researchers at Ann & Robert H. Lurie Children's Hospital of Chicago. [More]
Certain types of hormonal contraceptives may increase risk of seizures in women with epilepsy

Certain types of hormonal contraceptives may increase risk of seizures in women with epilepsy

Could certain types of hormonal contraceptives cause an increase in seizures in women with epilepsy? A recent Texas A&M Health Science Center study suggests that ethinyl estradiol, the primary component of oral contraceptives, could be detrimental to the epileptic brain. [More]
First aid in the past could have present-day policy implications

First aid in the past could have present-day policy implications

A widespread knowledge of first aid once equipped millions of people to tackle emergencies ranging from a cut finger to a life-threatening seizure. Could a revival of these skills help reduce pressure on doctors' surgeries and NHS casualty departments? [More]
Lack of UBE3A gene causes Angelman syndrome

Lack of UBE3A gene causes Angelman syndrome

The gene UBE3A plays a critical role in early neurological development. If UBE3A is overexpressed - or if the enzymatic function of UBE3A protein is hyperactive - autism ensues. A lack of functional UBE3A causes Angelman syndrome (AS), a neurodevelopmental disorder characterized by severe developmental delay, motor deficits, absence of speech, and, in most cases, epilepsy. [More]
FDA proposes to change regulation of ECT treatment

FDA proposes to change regulation of ECT treatment

For decades, people with severe depression, bipolar disorder, and other major mental health conditions have gotten help from the treatment known as ECT, when nothing else helped them. [More]
Anticonvulsant medication gabapentin effectively reduces common complication of PONV

Anticonvulsant medication gabapentin effectively reduces common complication of PONV

The anticonvulsant medication gabapentin—already a useful part of strategies to control pain after surgery—also effectively reduces the common complication of postoperative nausea and vomiting (PONV), reports a study in Anesthesia & Analgesia. [More]
Stimulus-induced discharges in critically ill not linked to in-hospital death

Stimulus-induced discharges in critically ill not linked to in-hospital death

Stimulus-induced rhythmic, periodic or ictal discharges in critically ill patients are not independently associated with in-hospital death, but are often associated with other electrographic abnormalities signalling poor outcomes, electroencephalography findings show. [More]
Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe. [More]
Drexel University researchers explore effective drug for treating established status epilepticus

Drexel University researchers explore effective drug for treating established status epilepticus

Drexel University College of Medicine researchers are conducting an emergency medicine study to find out the most effective drug for treating established status epilepticus -- a life-threatening condition in which the brain is in a state of persistent seizure. [More]
Heart rate variability may increase epilepsy risk

Heart rate variability may increase epilepsy risk

Doctors have long characterized epilepsy as a brain disorder, but researchers at Case Western Reserve University have found that part of the autonomic nervous system functions differently in epilepsy during the absence of seizures.This connection to the involuntary division of the nervous system may have implications for diagnosing and treating the disease and understanding sudden unexpected death in epilepsy [More]
Hemispheric and thalamic volumes point to electrical epilepticus during sleep

Hemispheric and thalamic volumes point to electrical epilepticus during sleep

Early assessment of hemispheric and thalamic volumes in children with polymicrogyria and epilepsy can reliably predict the risk of continuous spike-and-wave complexes during sleep, a study indicates. [More]
New model could help to better understand extreme events in the brain

New model could help to better understand extreme events in the brain

Physicists at the Universities of Bonn and Oldenburg have developed a model whose behavior - although based on strict rules - can apparently change spontaneously. There are also changes of this type in nature, for example, in the development of migraine attacks or epileptic seizures. [More]
ViiV Healthcare presents positive results from LATTE-2 study at CROI

ViiV Healthcare presents positive results from LATTE-2 study at CROI

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the LATTE-2 study at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Headline results were announced in November 2015. [More]
Briviact (brivaracetam) approved for treatment of partial onset seizures in patients with epilepsy

Briviact (brivaracetam) approved for treatment of partial onset seizures in patients with epilepsy

The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with epilepsy. [More]
Advertisement
Advertisement